Navigation Links
Viralytics Full Year Financial Results
Date:9/3/2013

SYDNEY, Sept. 3, 2013 /PRNewswire/ -- Viralytics Limited (ASX:VLA, OTCQX:VRACY) has released its financial results for the year ended 30 June 2013. 

 Financial ResultsNet cash used in operating activities for the Year

$3.9 millionCash position at the end of the Year

$5.1 millionReported loss

$4.1 million 

Operational HighlightsCAVATAK™ Phase II CALM Melanoma Clinical Trial (USA) Highlights include:

  • CAVATAK™ presented at the American Society of Clinical Oncologists conference in June 2013 and the World Melanoma Congress in July 2013 to a global oncology audience.
  • Key milestone achieved with enrolment of the 35th patient. Independent Data Monitoring Committee reported that CAVATAK™ had met safety and tolerability criteria.
  • Patient enrolment now at 10 prestigious US cancer clinics, with acceleration since early 2013. Aiming for full recruitment by the end of the calendar year.
  • 23 patients have reached assessment point against the trial's primary endpoint of immune related Progression Free Survival (irPFS) at 6 months. Interim results very promising with 8 of 23 patients having achieved the primary endpoint. Trial target is 10 of 54 evaluable patients achieving primary endpoint.
  • 2 complete and 6 partial tumour responses from 30 assessable patients. Anti-cancer activity demonstrated in non-injected (metastatic or secondary) as well as the injected tumours.
  • CAVATAK™ Phase I studies completed (Australia)

  • Intravenously administered CAVATAK™ well tolerated in late stage cancer patients.
  • Some evidence of tumour stabilization in intravenous study after only a single dose.
  • Sound basis for a multi-dose intravenous Phase 1 / 2 trial (our STORM study).
  • CAVATAK™ Preclinical studies completed (A
    '/>"/>

    SOURCE Viralytics Ltd.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2013 Financial Results
    2. International Isotopes Inc. Announces Second Quarter and Six Months 2013 Financial Results
    3. ULURU Inc. Reports Second Quarter 2013 Financial Results
    4. Tengion Provides Business Update and Reports Second Quarter 2013 Financial Results
    5. EntreMed Reports Second Quarter 2013 Financial Results
    6. Savient Pharmaceuticals Reports Second Quarter 2013 Financial Results
    7. Sinovac Reports Unaudited Second Quarter 2013 Financial Results
    8. Vasomedical Announces Financial Results for the Second Quarter of 2013
    9. Nephros Reports Second Quarter 2013 Financial Results
    10. Regulus Reports Second Quarter 2013 Financial Results and Recent Highlights
    11. Dynasil Corporation of America Reports Third Quarter Fiscal 2013 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/27/2015)... Feb. 27, 2015  Organovo Holdings, Inc. (NYSE ... on delivering breakthrough 3D bioprinting technology, announced today ... Executive Officer, will present live at VirtualInvestorConferences.com on ... to join us for this Company update," said ... our commercial launch of the exVive3D Liver, Bioprinted ...
    (Date:2/27/2015)... and JERUSALEM , Feb. ... company developing octreotide capsules, its lead product for the ... $70 million Series E financing round. Participants in the ... Ventures, and an undisclosed blue chip public investment fund, ... 7 Med Health Ventures, Abingworth and ARCH Venture Partners. ...
    (Date:2/26/2015)... Feb. 26, 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... manufacturer of the t:slim® and t:flex™ Insulin Pumps, today ... 5,250,000 shares of its common stock at a price ... proceeds to Tandem from this offering are expected to ... and other estimated offering expenses payable by Tandem. All ...
    Breaking Medicine Technology:Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 2Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 4Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3
    ... 2012 Bionovo, Inc. (OTCQB: BNVI), a pharmaceutical company focused ... treatments for women,s health and cancer, announced today that ... that the Phase 3 trial of Menerba (MF101) could ... clinical safety and tolerability data. Menerba is Bionovo,s oral ...
    ... leaders of "America,s pastime," a free open-source screen-reading software company, ... Camp Abilities have in common? All have taken successful strides ... are blind or visually impaired, which is why they were ... by the American Foundation for the Blind (AFB). Chosen ...
    Cached Medicine Technology:Bionovo's Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™ 2Bionovo's Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™ 3Bionovo's Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™ 4American Foundation for the Blind Announces 2012 Access Award Winners 2American Foundation for the Blind Announces 2012 Access Award Winners 3
    (Date:2/28/2015)... February 28, 2015 In recent years Medical ... of practicing physicians as a way for them to expand ... regarding Cannabis as medicine. Since the FDA still lists Cannabis ... resources available to licensed physicians that can help guide ... Dr. Deborah Malka in Santa Cruz, CA is a ...
    (Date:2/28/2015)... February 28, 2015 Gerald “Solutionman” Haman ... blocks or barriers to innovative thinking. “The #1 ... was lack of tools,” reports Haman, who created the ... 57% of people felt that they did not have ... tools and resources to stimulate innovation. , Solutionman’s monthly ...
    (Date:2/28/2015)... The Classic Denture Center , located ... Throughout all of March patients can receive $25 ... service can help overall mouth health and give ... notice certain symptoms that suggest the denture teeth are ... , 1.    Pain, clicking, and popping in the joints, 2.    Pain ...
    (Date:2/28/2015)... Vancouver personal injury lawyers at Jiwa Law Corporation ... time limits. They stated that in many cases, missing an ... nullify it. Many a time, delays in making an injury ... BC law. As a result, experts at Jiwa Law Corporation ... a personal injury lawyer in order to know more about ...
    (Date:2/28/2015)... February 28, 2015 For those people ... person, the Mesothelioma Applied Research Foundation (Meso ... Tuesday, March 3, starting at 9:30 AM. , The ... registration. The broadcast can be accessed through any browser ... . , The Symposium is a unique event that ...
    Breaking Medicine News(10 mins):Health News:Reputable Cannabis Doctor In Santa Cruz and Monterey Joins the Medical Cannabis Network 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 3Health News:Classic Denture Center in Portland Oregon is Offering March Discount 2Health News:Jiwa Law Corporation Recently Announced That Time Delays May Weaken Personal Injury Claims 2Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2
    ... cancer, the side effects of chemotherapy and other ... research based on nano- and microtechnology from Tel ... as more effective cancer treatment. , New drug ... Tel Aviv University,s Department of Biochemistry allows drugs ...
    ... Feb. 19 A new analysis from the JUPITER ... in San Diego, California describes details of the stroke ... This data adds to the primary analysis of ... 20mg significantly reduced the risk of stroke by nearly ...
    ... Cholesterol-lowering statins, used by millions of Americans to ... problems, according to researchers at Texas Health Presbyterian ... and the influence of statin drugs," appears in ... physicians make quicker, more accurate diagnoses of suspected ...
    ... address the unmet and undiagnosed health needs of students ... communities , Alliance College -Ready Public School,s College-Ready ... Street, Los Angeles, 90015 will host a free school ... 11:00 a.m. to 3:00 p.m. Students and families attending ...
    ... marketing promotional products company, offers a specialty store filled with ... ... Lewiston, ME (PRWEB) February 19, 2009 -- Crestline Custom ... that trades on its easy, customer-friendly ordering process, offers scores ...
    ... Mardil Inc., a cardiac medical device company with ... the appointment of Daniel A. Pelak to its board ... of cardiac medical devices will serve as a guiding ... its unique device from the development stage to human ...
    Cached Medicine News:Health News:New 'bubble' targets only cancer cells 2Health News:CRESTOR Cuts Risk of Stroke by Nearly Half in JUPITER Study 2Health News:CRESTOR Cuts Risk of Stroke by Nearly Half in JUPITER Study 3Health News:CRESTOR Cuts Risk of Stroke by Nearly Half in JUPITER Study 4Health News:Dallas Scientists Discover Statins May Falsely Indicate Thyroid Problems 2Health News:High Achieving Los Angeles Charter School to Hold Health Fair Offering Free Medical Screening, Treatment and Information to Students and Their Families 2Health News:Crestline is the Source for Great Green Giveaways 2Health News:Crestline is the Source for Great Green Giveaways 3Health News:Mardil Inc. Appoints Medical Device Veteran Daniel A. Pelak to Its Board of Directors 2
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: